普通外文研报
STARTING IN 30 MINUTES: Guggenheim Grand Rounds - The Good, The Bad, and The Ugly in Pulmonary Fibrosis Drug Development with Two Leading Experts
研报英文原文证据摘录
STARTING IN 30 MINUTES: Guggenheim Grand Rounds - The Good, The Bad, and The Ugly in Pulmonary Fibrosis Drug Development with Two Leading Experts
pective Representatives make any representation
or warranty regarding, accuracy or completeness of any information contained therein
or otherwise. Neither Guggenheim nor any other Presenter nor any of their respective
Representatives shall be liable to any person in any way whatsoever for any losses, costs
or claims for reliance on the materials. Guggenheim and/or any other Presenter may have a
business relationship with certain attendees and/or issuers mentioned during the event or in
any materials provided, or may otherwise underwrite, hold a position, buy or sell as principal
in the securities of any issuer mentioned. Guggenheim may have in the past provided, may
currently be providing and may in the future seek to provide investment banking, financial
advisory and other services to, and have other material relationships with, attendees and/
or issuers of securities, loans and other financial instruments discussed during the event or
referred to in any materials. With respect to any position Guggenheim or any Presenter may
hold, Guggenheim or such Presenter may have interests different from or adverse to your
interests. None of the materials provided may be reproduced or redistributed, in whole or in
part, to any other person or published in whole or in part for any purpose absent the written
consent of Guggenheim. By registering for and/or attending the event and/or accepting
delivery of the materials, you will be deemed to acknowledge and agree to the matters set
forth above. Copyright 2026 by Guggenheim Securities, LLC, a FINRA registered broker-
dealer. All rights reserved. Invitation is non-transferable.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器